Results 41 to 50 of about 10,553 (137)
Beilstein Journal of Nanotechnology, 2015 In this work, cytotoxicity and cellular impedance response was compared for CdSe/ZnS core/shell quantum dots (QDs) with positively charged cysteamine–QDs, negatively charged dihydrolipoic acid–QDs and zwitterionic D-penicillamine–QDs exposed to canine ...
Vladimir V. Breus +4 more
doaj +1 more source
WILSON'S DISEASE IN CHILDREN, REPORT OF 25 CASES [PDF]
Acta Medica Iranica, 1984 We conducted a retrospective study of 25 cases (15 boys and 12 girls) of Wilson's disease(Hepatolenticular degeneration)spanning a period of 8 years. Age at the time of diagnosis ranged between 3-17 years. The f ollowing clinical forms were observed:
Y. AGHIGHI, R. AFTENDELIANS
doaj
Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease
La Pediatria Medica e Chirurgica, 2012 We describe a case of nephrotic syndrome (NS) after a 7 months treatment with D-penicillamine in a 14 years old girl with Wilson’s disease , with a prompt regression at the discontinuation of the drug.
M. Farallo +4 more
doaj +1 more source
Revista Brasileira de Reumatologia, 2004 OBJETIVO: mostrar a evolução de quatro pacientes para remissão clínica completa da esclerose sistêmica (ES), sem necessidade de tratamento medicamentoso atual, após uso de D-penicilamina como medicação principal.
Leandro Antônio Cichoski +3 more
doaj +1 more source
Evaluation of vitamin B6 supplementation in Wilson's disease patients treated with D-penicillamine. [PDF]
BMJ Open Gastroenterol, 2023 Mbala J +4 more
europepmc +1 more source
JHEP ReportsBackground & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of ...
Peter Ott +16 more
doaj +1 more source
Comparative management practices of Wilson disease in Californian and Italian providers
Journal of Health, Population and NutritionBackground There is a scarcity of randomized and high-quality studies to aid clinicians in management and treatment of Wilson disease (WD). Even amongst society practice guidelines in North America and Europe, diagnosis and management of WD varies.
Sandy Vien +4 more
doaj +1 more source
A rare case of DIC in a patient with Wilson's disease: D-penicillamine. [PDF]
Hepatol Forum, 2022 Emre Parlar Y +4 more
europepmc +1 more source
Arquivos de Neuro-Psiquiatria, 1969 The metabolic balances of sulfur in two cases of hepatolenticular degeneration were studied. A positive balance was found in both cases; in one patient submitted to mixed diet, the average was significantly higher than the normal mean. The administration
Horacio M. Canelas +2 more
doaj